News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,096 Results
Type
Article (5097)
Company Profile (24)
Press Release (226975)
Multimedia
Podcasts (2)
Webinars (4)
Section
Business (82262)
Career Advice (463)
Deals (15059)
Drug Delivery (8)
Drug Development (19081)
Employer Resources (30)
FDA (3683)
Job Trends (3910)
News (120210)
Policy (7516)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (293)
Accelerated approval (6)
Adcomms (4)
Allergies (14)
Alliances (14809)
ALS (38)
Alzheimer's disease (295)
Antibody-drug conjugate (ADC) (40)
Approvals (3783)
Artificial intelligence (80)
Autoimmune disease (27)
Automation (5)
Bankruptcy (97)
Best Places to Work (2866)
Biosimilars (32)
Biotechnology (23)
Bladder cancer (34)
Brain cancer (7)
Breast cancer (101)
Cancer (887)
Cardiovascular disease (61)
Career advice (395)
Career pathing (3)
CAR-T (64)
CDC (2)
Cell therapy (166)
Cervical cancer (5)
Clinical research (16690)
Collaboration (353)
Compensation (373)
Complete response letters (8)
COVID-19 (311)
CRISPR (13)
C-suite (338)
Cystic fibrosis (28)
Data (1327)
Denatured (1)
Depression (21)
Diabetes (78)
Diagnostics (2114)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (31)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (36)
Earnings (42739)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (39159)
Executive appointments (424)
FDA (4421)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (341)
Gene editing (24)
Generative AI (5)
Gene therapy (102)
GLP-1 (144)
Government (423)
Guidances (197)
Healthcare (5046)
HIV (10)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (39)
Immuno-oncology (7)
Indications (16)
Infectious disease (337)
Inflammatory bowel disease (36)
Inflation Reduction Act (3)
Influenza (6)
Intellectual property (32)
Interviews (53)
IPO (7883)
IRA (3)
Job creations (1122)
Job search strategy (361)
JPM (4)
Kidney cancer (10)
Labor market (10)
Layoffs (106)
Leadership (5)
Legal (2338)
Liver cancer (21)
Longevity (2)
Lung cancer (93)
Lymphoma (70)
Machine learning (3)
Management (10)
Manufacturing (139)
MASH (50)
Medical device (3927)
Medtech (3937)
Mergers & acquisitions (7581)
Metabolic disorders (215)
Multiple sclerosis (18)
NASH (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (12)
Neuroscience (540)
NextGen: Class of 2026 (1674)
Non-profit (731)
Now hiring (5)
Obesity (85)
Opinion (32)
Ovarian cancer (26)
Pain (26)
Pancreatic cancer (38)
Parkinson's disease (50)
Partnered (6)
Patents (52)
Patient recruitment (97)
Peanut (6)
People (25231)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (4999)
Phase 2 (7228)
Phase 3 (5789)
Pipeline (1970)
Policy (17)
Postmarket research (625)
Preclinical (1947)
Press Release (66)
Prostate cancer (57)
Psychedelics (3)
Radiopharmaceuticals (109)
Rare diseases (180)
Real estate (1887)
Recruiting (8)
Regulatory (5541)
Reports (17)
Research institute (308)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (2)
Schizophrenia (49)
Series A (53)
Series B (55)
Sickle cell disease (10)
Special edition (1)
Spinal muscular atrophy (33)
Sponsored (5)
Startups (1017)
Stomach cancer (1)
Supply chain (13)
Tariffs (7)
The Weekly (1)
Vaccines (80)
Venture capital (9)
Weight loss (30)
Women's health (6)
Date
Today (15)
Last 7 days (146)
Last 30 days (528)
Last 365 days (8899)
2026 (799)
2025 (9036)
2024 (11031)
2023 (13195)
2022 (18660)
2021 (19682)
2020 (18245)
2019 (13208)
2018 (10210)
2017 (10010)
2016 (9163)
2015 (12138)
2014 (9598)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (186)
Alabama (19)
Alaska (2)
Arizona (74)
Arkansas (1)
Asia (11783)
Australia (1691)
California (3541)
Canada (1138)
China (168)
Colorado (143)
Connecticut (162)
Delaware (70)
Europe (25499)
Florida (542)
Georgia (67)
Idaho (24)
Illinois (161)
India (14)
Indiana (105)
Iowa (9)
Japan (165)
Kansas (36)
Kentucky (17)
Louisiana (8)
Maine (51)
Maryland (352)
Massachusetts (2807)
Michigan (104)
Minnesota (202)
Mississippi (1)
Missouri (32)
Montana (17)
Nebraska (12)
Nevada (46)
New Hampshire (16)
New Jersey (1020)
New Mexico (5)
New York (815)
North Carolina (480)
North Dakota (4)
Northern California (1854)
Ohio (116)
Oklahoma (5)
Oregon (6)
Pennsylvania (597)
Puerto Rico (1)
Rhode Island (19)
South America (279)
South Carolina (17)
Southern California (1304)
Tennessee (61)
Texas (483)
United States (12342)
Utah (111)
Virginia (84)
Washington D.C. (17)
Washington State (297)
West Virginia (2)
Wisconsin (57)
Wyoming (1)
232,096 Results for "cerus corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook
January 12, 2026
·
9 min read
Press Releases
Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting
October 22, 2025
·
4 min read
Business
Cerus Corporation Announces First Quarter 2024 Financial Results
Cerus Corporation (Nasdaq: CERS) today announced financial results for the first quarter ended March 31, 2024.
May 2, 2024
·
19 min read
Biotech Bay
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion.
June 21, 2024
·
3 min read
Biotech Bay
Cerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor Conference
Cerus Corporation (Nasdaq: CERS) announced today that Kevin Green, Cerus’ chief financial officer, is scheduled to participate at the 21st Annual Craig-Hallum Institution Investor Conference in Minneapolis, on Wednesday, May 29th.
May 22, 2024
·
1 min read
Biotech Bay
Cerus Corporation to Participate in Upcoming Investor Conferences - February 1, 2024
Cerus Corporation (Nasdaq: CERS) announced management participation in two upcoming investor conferences.
February 1, 2024
·
1 min read
Business
Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024
Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2024 financial results will be released on Thursday, May 2, 2024, after the close of the stock market.
April 18, 2024
·
1 min read
Business
Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results
Cerus Corporation (Nasdaq: CERS) today announced financial results for the fourth quarter and full year ended December 31, 2023.
March 5, 2024
·
19 min read
Press Releases
Cerus Corporation to Participate in Upcoming Investor Conferences
November 13, 2024
·
1 min read
Biotech Bay
Cerus Corporation to Participate in Upcoming November 2023 Investor Conferences
Cerus Corporation announced that the Company will participate in two upcoming investor conferences.
November 3, 2023
·
1 min read
1 of 23,210
Next
